Research Roundup

COPD treatments; celecoxib; HRT and risk of venous thromboembolism... Debbie Rigby takes a look at the latest in research news Dual combination therapy versus long‐acting bronchodilators alone for COPD A systematic review and network meta‐analysis of 99 studies (n=101,311) has concluded that LABA/LAMA combination bronchodilators reduce COPD exacerbations more than LABA/ICS combination, LAMA, and LABA